MedWatch

Danish life science company goes public in Sweden

The Danish company 2curex has announced its arrival on Nasdaq First North in Stockholm. According to the CEO, the reason is not lack of money; the timing is simply right for the company behind the IndiTreat-technology used to identify the most effective medical treatment for cancer patients.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

GSK får FDA nik til potentiel revolutionerende HIV-behandling

GSK har fået grønt lys fra de amerikanske lægemyndigheder, FDA, til selskabets mest lovende HIV-middel. Tilladelsen kan være indledningen til et paradigmeskifte inden for HIV-behandling, idet behandlingen reducerer antallet af lægemidler, patienterne behøver at tage.

Latest Top picks in English

Related articles